Why Your Sales Problem Isn't a Sales Problem

TLDR;-) Sales is the most common coaching and advisory theme across projects I've worked on.
In the majority of cases, the actual problem isn't sales. It's unresolved positioning, unvalidated evidence, or an ICP that changes with every meeting. Founders invest in sales infrastructure on top of dependencies that haven't been resolved. The methodology fails not because it's wrong but because it was applied to a problem it wasn't designed to solve.

Sales surfaces as the presenting theme in roughly 80% of my coaching sessions and advisory engagements. Founders arrive with clear requests: "I need help with my pipeline." "I need a sales playbook." "I need to hire a VP of Sales."

In most of those sessions, the actual work that produces progress has nothing to do with sales execution. The ICP is undefined. The positioning shifts depending on who's in the room. The pilot evidence exists but hasn't been packaged into anything a buyer's organisation can act on. The founder is investing in commercial engine infrastructure on top of unresolved upstream dependencies.

This is a sequencing error, not a skills gap. And it's fixable, once you see it.

I've written elsewhere about how innovation effort follows a dependency sequence: each layer gates the next, and effort spent downstream before upstream prerequisites are resolved produces misleading signals. (The full framework is in [Critical Path Layers: A Dependency Map for Innovation].) In sales terms: Layer 1 is market clarity (ICP, positioning, pricing). Layer 2 is validation (pilot evidence, corporate engagement, proof that the buyer's organisation can adopt). Layer 3 is the commercial engine (pipeline, sales process, team). Most founders experiencing "sales problems" are working on Layer 3 while Layers 1 and 2 remain unresolved.

The pattern has a name. I call it downstream gravity: the pull toward visible, activity-rich work at the layer where effort feels most like progress. Sales activity feels like progress. Calls, demos, proposals, follow-ups. It generates data. The problem is that when the upstream dependencies aren't resolved, the data is noise.

Three signs your sales problem isn't a sales problem

These are patterns I see repeatedly. They look like sales execution failures. They aren't.

• The pitch keeps changing. Every prospect gets a different deck. The founder adapts the story in real time based on who's in the room. The team calls this "versatility" or "consultative selling." It's neither. It's the absence of a stable value proposition, which is the absence of a resolved ICP.

If you don't know who you're selling to, you can't stabilise what you're saying. The pitch changes because the target changes. No sales methodology can compensate for this. Challenger assumes you have a differentiated insight. Sandler assumes you can articulate pain in the buyer's vocabulary. Both assume the who is settled. It isn't.

Diagnostic question: Can you describe your ideal customer to a new hire in under 60 seconds, with enough specificity that they could identify a target account from it?

• The pilot converts but the pipeline doesn't. The company has two or three happy customers. The product works. But new conversations stall at proposal stage, or prospects go dark after the first meeting. The founder can close deals through personal credibility, domain expertise, and sheer persistence. Nobody else can.

This looks like a conversion problem. It's a validation problem. The evidence from existing customers hasn't been translated into proof that stands on its own. The founder's personal authority substitutes for documented evidence. When that authority isn't in the room, there's nothing to carry the argument.

Dixon and McKenna's research on 2.5 million recorded sales conversations found that 40 to 60% of B2B deals end in "no decision." Of those losses, 56% stem from customer indecision, not satisfaction with the status quo. The three drivers: valuation problems, information gaps, and outcome uncertainty. All three are evidence failures, not sales execution failures.

Diagnostic question: Could someone other than you present your pilot evidence to a prospect and make the case, without tribal knowledge, founder charisma, or personal network?

• The first sales hire failed. The company brought in a VP of Sales or senior account executive who underperformed and left within 12 months. The board thinks it was a hiring mistake. The founder suspects the same.

It probably wasn't. Jason Lemkin has cited survey data suggesting roughly 70% of first VP of Sales hires don't last 12 months. CloserIQ's 2017 analysis showed average VP Sales tenure at early-stage startups declining from 26 months to 19 months. OpenView Partners found 68% of first VP Sales hires leave within 18 months. The numbers are directional, not rigorous, but the pattern is too consistent to dismiss.

The failure mode Mike Molinet captures precisely: "When you make a sales hire too early, you're now evaluating whether that person is successful, whether you have a repeatable sales process, and whether the product is even aligned to solve the right problem." Three variables confounded simultaneously. You can't isolate what failed because you didn't have enough resolved before the hire began.

Mark Roberge's analysis of hundreds of startups over 25 years at Stage 2 Capital and HubSpot identifies five dominant failure modes. All five are upstream: premature revenue focus, inadequate product-market fit definitions, misunderstanding go-to-market prerequisites, front-loading sales hires, and confusing temporary competitive advantage with lasting differentiation.

The sales hire was asked to systematise something that hadn't been discovered yet. That's not a hiring problem. That's a sequencing problem.

Diagnostic question: If your best salesperson left tomorrow, could anyone close a deal using only documented materials?

What every sales methodology assumes you've already done

Every major B2B sales methodology shares a structural feature that its proponents rarely make explicit: none of them help a company figure out who its buyer is, what pain exists, or whether its solution addresses that pain. Every methodology begins after those questions are answered.

• Challenger Sale. Matthew Dixon and Brent Adamson's research at CEB found that 40% of top-performing sales reps are "Challengers" who teach buyers something new, tailor messages to stakeholders, and take control of the sale. The entire framework rests on the "commercial insight," a reframe that challenges the buyer's mental model and leads uniquely to your solution.

The commercial insight IS your positioning. It's the Layer 1 output. If your positioning is "we're an AI platform that helps enterprises optimise operations," you don't have a commercial insight. You have a category description. Dixon and Adamson are explicit: Marketing must serve as "the insight generation machine" keeping reps equipped. Johnny Grow's practitioner analysis confirms the dependency: "It's inefficient for sellers to develop meaningful customer insights. This is a job typically best done by Marketing." If a company lacks validated commercial insights, Challenger execution produces pushiness, not teaching.

• MEDDIC. Dick Dunkel and Jack Napoli built MEDDIC at PTC in the 1990s as a deal qualification framework. Force Management's John Kaplan calls it "an X-ray" that identifies gaps in deals. It helped PTC grow from $300M to $1B in four years. MEDDIC assumes the company already has validated, quantifiable value claims (Metrics), already knows what an economic buyer looks like in its target market (Economic Buyer), and has enough pipeline to afford disqualifying deals.

These are Layer 2 outputs. If you haven't validated your pilot evidence and mapped the buyer's decision-making structure, MEDDIC becomes a checklist you can't fill in. Oliv.ai's practitioner analysis documents the decay pattern: "Poorly trained reps treat MEDDIC as an interrogation checklist rather than consultative discovery," and methodology adherence collapses within three to six months.

• Sandler. David Sandler's system uses upfront contracts, a Pain Funnel, and budget qualification to separate buyers from browsers. Its core assumption, per Dock.us analysis: "David Sandler believed that if you have something worth buying, you shouldn't have to knock down the door. Buyers should invite you in." Pain articulation in the buyer's vocabulary is Layer 1 work: ICP plus value proposition. Budget qualification requires Layer 2: a validated business case. For startups without brand reputation or inbound demand, the "motivated buyer" assumption collapses immediately.

The cross-cutting finding is stark. All major methodologies assume a validated ICP, validated problem-solution fit, defined buyer personas, and working demand generation. The more sophisticated the methodology, the more upstream infrastructure it requires. No methodology includes a step that says: "First, check whether you know who your buyer is."

The founders who succeed with these methodologies aren't better at sales. They completed the upstream work first. The methodology organised what they'd already discovered. It didn't discover it for them.

April Dunford states this directly in Sales Pitch: "There's a lot of deep thinking going on around sales methodologies and how to handle objections. It all just kind of assumes that a pitch just exists." Her 200-plus client engagements confirm the sequence: positioning, then pitch, then methodology.

When sales investment is actually right

The argument here is not anti-sales. Sales investment is the right move. At the right time.

Mark Leslie and Charles Holloway published "The Sales Learning Curve" in Harvard Business Review, drawing on Leslie's experience growing Veritas Software from $95K to $1.5B in revenue. Their core principle: "Hiring a full sales force too early just causes the firm to burn through cash and fail to meet revenue expectations."

Leslie's three-phase model defines the dependency chain:

1. The Initiation Phase (Sales Yield below 1x cost per rep) requires what he calls "Renaissance Reps," three to four maximum, comfortable with ambiguity, part salesperson and part product manager. This is founder-led sales with lightweight support. You're still learning.
   

2. The Transition Phase (Sales Yield 1x to 2x) calls for "Enlightened Reps" who refine a developing process. This is where you test whether what worked for the founder can work for someone else.
   

3. The Execution Phase (Sales Yield above 2x) is when "Coin-Operated Reps," traditional quota-carrying performers, can be hired at scale. The process is documented, the ICP is stable, the evidence speaks for itself.

Lemkin's framework reinforces this from the operator side: close 10 unaffiliated customers yourself (not friends, investors, or programme batchmates), then hire two account executives simultaneously (never one: with one failure you can't distinguish rep failure from process failure), then hire a VP of Sales only when two reps consistently hit quota.

Steve Blank's Customer Development draws the sharpest line: "If you hire a VP of Sales with the idea that they can do customer discovery, you violated the first principle of Customer Development. This isn't a step that can be outsourced to a non-founder."

There's a distinction here that multiple sources circle around but none quite name. Founder-led selling has two modes. The first is selling to learn: discovery conversations, hypothesis testing, refining the ICP. This is upstream work in progress. The second is selling because the knowledge isn't delegable yet: the founder has tacit understanding of the buyer, the pain, the objection patterns, but hasn't documented any of it. The second mode is a signal that upstream work hasn't been completed enough to hand over. It looks like effective founder selling. It's actually a bottleneck.

Readiness signals that Layers 1 and 2 are sufficiently resolved:

You have at least three to five customers who bought for the same reason. Not five customers who each bought for a different reason.

Your pilot evidence is documented well enough that someone other than you can present it to a prospect.

A prospect who fits your ICP can explain back to you, in their own words, what problem you solve.

Your first hire profile is discovery-oriented, not methodology-oriented. You're hiring someone to systematise what works, not to figure out what works. The second is still founder-led sales wearing a job title.

Dave Kellogg defines the proof metric precisely: "80% of sales reps at 80% of quota is healthy." If you're nowhere near that, the question is whether the constraint is sales execution (inconsistent rep performance with the same leads, long ramp times despite good product-market fit) or upstream (high demo-to-close dropoff, rapid post-purchase churn, wildly inconsistent ICP across closed deals).

The diagnostic

80% of my sessions with executives across coaching and advisory sessions that surfaced sales as the presenting theme produced, in most cases, upstream work as the output. The leaders and teams who came asking for pipeline left working on positioning. The ones who came asking for a sales methodology left clarifying their ICP. The ones who came asking about hiring a VP of Sales left documenting what they'd learned during founder-led selling.

The reframe isn't "you're bad at sales." It's "you're solving the wrong problem at the wrong layer."

Three questions to locate where you actually are:

• If your best salesperson left tomorrow, could anyone else close a deal using only documented materials, no tribal knowledge, no founder charisma, no personal network?

• Can you describe the buying process your customers go through, not your sales process but their buying process, with enough specificity that you could train a new hire on it?

• When you lose a deal, do you know which layer failed: the value proposition, the evidence, or the sales execution?

Sales methodology is a Layer 3 tool. If you're struggling at Layer 1 or 2, the best sales playbook in the world will organise your failure more efficiently. Assess where you are with our micro-diagnostic interactive tool here

Alexandra Najdanovic is the founder of Aieutics, working with founders and leadership teams on strategic transformation and AI-readiness.

Further reading

• April Dunford, Sales Pitch (2023). The clearest articulation of the positioning-before-methodology sequence, grounded in 200-plus client engagements.

• Mark Roberge, The Science of Scaling (2025). Five failure modes of premature sales investment, drawn from the former HubSpot CRO's analysis of hundreds of startups.

• Mark Leslie and Charles Holloway, "The Sales Learning Curve," Harvard Business Review (2006). The definitive readiness framework for when to hire and at what level, with Leslie's three-phase model.

• Max Marmer, Bjoern Lasse Herrmann, Ron Berman, Startup Genome Report (2011). The most-cited empirical study on premature scaling: 74% of high-growth startup failures traced to doing too much too soon.

• Alexandra Najdanovic, "Critical Path Layers: A Dependency Map for Innovation," Aieutics (2026). The framework that explains why sales problems are often Layer 1 or Layer 2 problems in disguise.